Kiley Juergens Wealth Management, LLC Pfizer Inc Transaction History

Kiley Juergens Wealth Management, LLC

$417 Million
Q2 2025

A detailed history of Kiley Juergens Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kiley Juergens Wealth Management, LLC holds 16,543 shares of PFE stock, worth $395,873. This represents 0.1% of its overall portfolio holdings.

Number of Shares

16,543

Previous 15,442 7.13%

Holding current value

$395,873

Previous $391,000 2.56%

% of portfolio

0.1%

Previous 0.11%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$21.59 - $24.84 $23,770 - $27,348	1,101 Added 7.13%	16,543 $401,000
Q1 2025 Apr 21, 2025	SELL	$25.01 - $27.13 $11,054 - $11,991	-442 Reduced 2.78%	15,442 $391,000
Q4 2024 Jan 16, 2025	SELL	$24.8 - $30.19 $21,650 - $26,355	-873 Reduced 5.21%	15,884 $421,000
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $21,329 - $24,170	-770 Reduced 4.39%	16,757 $484,000
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $6,112 - $7,163	-242 Reduced 1.36%	17,527 $490,000
Q1 2024 Apr 18, 2024	SELL	$25.89 - $29.73 $17,087 - $19,621	-660 Reduced 3.58%	17,769 $493,000
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $158,792 - $206,253	-6,077 Reduced 24.8%	18,429 $530,000
Q3 2023 Oct 17, 2023	SELL	$32.09 - $37.51 $70,437 - $82,334	-2,195 Reduced 8.22%	24,506 $812,000
Q2 2023 Jul 26, 2023	SELL	$36.12 - $41.79 $62,668 - $72,505	-1,735 Reduced 6.1%	26,701 $979,000
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $18,158 - $23,640	-461 Reduced 1.6%	28,436 $1.16 Million
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $2,546 - $3,324	61 Added 0.21%	28,897 $1.48 Million
Q3 2022 Oct 11, 2022	BUY	$43.76 - $53.42 $112,550 - $137,396	2,572 Added 9.79%	28,836 $1.26 Million
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $562,361 - $666,784	12,086 Added 85.24%	26,264 $1.38 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $362,111 - $448,701	-7,915 Reduced 35.83%	14,178 $734,000
Q1 2022 Apr 12, 2022	BUY	$45.75 - $56.69 $103,257 - $127,949	2,257 Added 11.38%	22,093 $1.14 Million
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $31,899 - $47,285	772 Added 4.05%	19,836 $1.17 Million
Q3 2021 Oct 13, 2021	SELL	$39.25 - $50.42 $16,720 - $21,478	-426 Reduced 2.19%	19,064 $819,000
Q2 2021 Jul 22, 2021	BUY	$35.91 - $40.68 $75,770 - $85,834	2,110 Added 12.14%	19,490 $763,000
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $5,525 - $6,232	-165 Reduced 0.94%	17,380 $629,000
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $28,616 - $36,388	855 Added 5.12%	17,545 $645,000
Q3 2020 Oct 23, 2020	SELL	$31.75 - $37.25 $208,375 - $244,471	-6,563 Reduced 28.22%	16,690 $612,000
Q2 2020 Jul 14, 2020	BUY	$30.12 - $36.54 $36,234 - $43,957	1,203 Added 5.46%	23,253 $760,000
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $45,004 - $64,302	1,665 Added 8.17%	22,050 $719,000
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $53,725 - $60,971	1,632 Added 8.7%	20,385 $798,000
Q3 2019 Oct 15, 2019	BUY	$32.49 - $42.13 $3,866 - $5,013	119 Added 0.64%	18,753 $673,000
Q2 2019 Jul 11, 2019	BUY	$36.98 - $41.52 $23,519 - $26,406	636 Added 3.53%	18,634 $807,000
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $23,475 - $25,791	626 Added 3.6%	17,998 $764,000
Q4 2018 Jan 15, 2019	BUY	$38.47 - $43.86 $8,078 - $9,210	210 Added 1.22%	17,372 $758,000
Q3 2018 Oct 10, 2018	BUY	$34.47 - $41.81 $199,512 - $241,996	5,788 Added 50.89%	17,162 $756,000
Q2 2018 Jul 23, 2018	BUY	$32.98 - $35.16 $15,962 - $17,017	484 Added 4.44%	11,374 $412,000
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $3,095 - $3,590	97 Added 0.9%	10,890 $386,000
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $358,975 - $380,884	10,793	10,793 $390,000

Others Institutions Holding PFE

# of Institutions

3,341

Shares Held

3.6B

Call Options Held

104M

Put Options Held

129M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $134B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiley Juergens Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kiley Juergens Wealth Management, LLC with notifications on news.

Account

Kiley Juergens Wealth Management, LLC Pfizer Inc Transaction History